Skip to main content

Table 1 The patient's clinical information

From: Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway

Patient information

Tumor (n = 20)

Age (year)

 ≤ 60

16

 > 60

4

Body mass index (BMI, kg/m2)

23.55 ± 2.60

International Federation of Gynecology and Obstetrics (FIGO) staging

 Stage I

18

 Stage II

0

 Stage III

2

 Stage IV

0

Histopathological type

 Endometrioid

19

 Serous

1

 Clear

0

 Others

0

Recurrence risk

 Low-risk

2

 Moderate-risk

10

 High-risk

8

 Unknown

0